Related Experiment Videos
Ethnicity and risk factors for coronary heart disease in diabetes mellitus
Insights
The Framingham equation predicts similar 10-year coronary heart disease (CHD) risk in South Asian and White Caucasian diabetic patients. However, differing risk factor profiles, like lower HDL cholesterol in South Asians, may explain higher CHD mortality in this group.
Area of Science:
- Cardiology
- Public Health
- Ethnic Health Disparities
Background:
- The Framingham equation is a tool for predicting coronary heart disease (CHD) risk and guiding interventions.
- Concerns exist regarding its applicability to South Asian populations due to high CHD mortality potentially not explained by traditional risk factors.
Purpose of the Study:
- To assess the accuracy of the Framingham equation in predicting 10-year CHD risk in diabetic patients of South Asian and White Caucasian origin.
- To compare the contribution of various risk factors to CHD risk between these ethnic groups.
Main Methods:
- The Framingham equation was applied to a cohort of 1826 diabetic patients (1215 White Caucasian, 611 South Asian).
- 10-year CHD risks were calculated, and the influence of risk factors was analyzed across ethnic groups.
Main Results:
- Mean 10-year CHD risk was comparable between South Asian and White Caucasian men (21.5% vs. 20.7%) and women (15.9% vs. 16.5%).
- South Asians exhibited lower total cholesterol and HDL cholesterol levels, resulting in higher total:HDL cholesterol ratios compared to White Caucasians.
- Significant differences (p < 0.05) were observed in cholesterol levels and ratios between the ethnic groups.
Conclusions:
- Despite similar predicted CHD risk, the underlying risk factor profiles differ significantly between South Asian and White Caucasian diabetic patients.
- Disparities in risk factor management may contribute to the elevated CHD mortality observed in individuals of South Asian descent.
Introduction:
The Framingham equation can be used to predict the risk of coronary heart disease (CHD) and so to target risk factor intervention. Reservations have been applied to its use in south Asian populations since the high CHD mortality in this group may not be accounted for by traditional risk factors.
Methods:
We applied the Framingham equation to 1826 patients with diabetes of whom 1215 were of white Caucasian and 611 south Asian origin. Having calculated the 10-year CHD risks the contribution of risk factors were compared between ethnic groups.
Results:
Mean 10-year CHD risk was the same in the two ethnic groups (20.7 vs. 21.5%, white Caucasian vs. south Asian men and 16.5 vs. 15.9%, white Caucasian vs. south Asian women). However, the risk factor profile was different between the two groups. Mean total cholesterol was lower in south Asians (5.23 vs. 5.41 mmol/l, south Asian vs. white Caucasian men (p = 0.01) and 5.38 vs. 5.68 mmol/l, south Asian vs. white Caucasian women (p < 0.001)). HDL cholesterol levels were also lower (median HDL cholesterol 0.94 vs. 1.11 mmol/l, south Asian vs. white Caucasian men (p < 0.001) and 1.07 vs. 1.3 mmol/l, south Asian vs. white Caucasian women (p < 0.0001)) leading to higher total: HDL cholesterol ratios (5.48 vs. 4.78, south Asian vs. white Caucasian men (p = 0.032) and 4.91 vs. 4.26, south Asian vs. white Caucasian women (p < 0.001).
Conclusion:
Calculated 10-year CHD risks are the same in south Asian and white Caucasian diabetic patients but the factors contributing to this risk differ. Different management of these risk factors may account for the higher mortality from CHD in those of south Asian origin.
Related Concept Videos
Coronary Artery Disease I: Introduction
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology